Sign In

Suraj Mudichintala

Venture Capital Investor at Arboretum Ventures

Suraj Mudichintala is a strategy-minded analytical thinker with a passion for problem-solving and making an impact on the world.

He earned his education in Management, Finance, and Business Analytics from Boston College, and also holds a High School Diploma with an impressive GPA from Freehold Borough High School.

Suraj has gained professional experience as a Venture Capital Investment Analyst at Arboretum Ventures, as well as past roles as an Associate at L.E.K. Consulting and a Commercial Advisory Intern at EY.

His diverse experience includes working as an EagleTech at Boston College ITS, an Assembly Product Intern at LSI Corporation, and an Office Manager at a Primary Care Clinic.

With a strong educational background and a range of professional experiences, Suraj Mudichintala is well-equipped to tackle complex challenges and drive positive change.

Highlights

Jan 16 · linkedin

Feels like an exciting time to be in #neurotech! Take a look at neurotech deal data in 2023; ~$1.18B invested across 105 deals in 2023, surpassing even 2021's invested capital by a hair.

While investment was driven by a concentrated group of deals (big shout out to Action Potential Venture Capital portfolio companies SetPoint Medical, Saluda Medical, and Presidio Medical, Inc., which accounted for $302M in VC-led investment in 2023), early stage deal activity in the space remains robust, and should lead to an exciting 2024!

What do you think about neurotech's 2024 outlook? More to come... cheers!

Suraj Mudichintala
Add to my network

Location

Ann Arbor, Michigan